ULTA
The numbers looked pretty, the stock did not
Ulta Beauty just turned in a quarter that would normally get the skincare-clap emoji treatment: comps rose 5.3%, gross margins expanded by 100 basis points, and earnings beat expectations. Management also raised full-year guidance — though not by as much as the first-quarter pop might have suggested, which is basically the corporate version of saying, “thanks, but we’re not done yet.”
Analysts liked it... with a side of skepticism
DA Davidson kept a Buy on the name but cut its price target from $650 to $585, which is a classic Wall Street move: thumbs-up, but make it less enthusiastic. The firm said comps, traffic, and ticket all moved in the right direction, and that the company is benefiting from better shrink, inventory sell-through, and mix.
Guggenheim was also constructive, reiterating a Neutral rating and calling the operating results broadly above expectations. It pointed to stronger prestige gains and a healthier newness cycle, but still flagged that the path ahead likely depends on Ulta wringing more efficiency out of SG&A if it wants to keep growth humming.
Why investors should care
The weird little lesson here is that beating on sales and profits isn’t always enough if the market thinks the easy wins are already behind you. Ulta is still showing it can grow, defend margins, and take share — but the stock near its 52-week low says investors want proof that this isn’t just a good quarter in a pretty box.
Big picture: Ulta’s still got the beauty bag packed, but Wall Street wants to see whether it can keep the glow going after the confetti settles.